# Central Mechanisms That Regulate Glucose Metabolism in Humans

> **NCT01028846** · PHASE4 · TERMINATED · sponsor: **Meredith Hawkins** · enrollment: 10 (actual)

## Conditions studied

- Type 2 Diabetes
- Glucose Metabolism Disorders
- Glucose, High Blood

## Interventions

- **DRUG:** Diazoxide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01028846
- **Lead sponsor:** Meredith Hawkins
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-11-02
- **Primary completion:** 2007-12-05
- **Final completion:** 2007-12-05
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** IRB approval expired 6/13/2023. Primary Completion Date and Study Completion Date updated after definitions were explained to PI/study team. Study never reached intended enrollment and will be categorized as terminated.
- **Last updated:** 2025-05-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01028846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01028846, "Central Mechanisms That Regulate Glucose Metabolism in Humans". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01028846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*